Neurology® Podcast
by American Academy of Neurology
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 39 chart positions in 39 markets.
By chart position
- 🇨🇦CA · Medicine#1055K to 30K
- 🇺🇸US · Medicine#1075K to 30K
- 🇲🇽MX · Medicine#3300K to 800K
- 🇫🇷FR · Medicine#3930K to 100K
- 🇧🇷BR · Medicine#4430K to 100K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
169K to 507K🎙 Daily cadence·1,000 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
563K to 1.7M🇲🇽47%🇫🇷6%🇧🇷6%+36 more - Active Followers
Loyal subscribers who consistently listen
169K to 507K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 20 epsHosts
Recent guests
Recent episodes
Exploring Military Sexual Trauma and Migraine Among US Veterans
Jul 20, 2026
22m 06s
Preparing ALS Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk Variants
Jul 16, 2026
14m 49s
When Drug Marketing Masquerades as Clinical Trials
Jul 13, 2026
17m 29s
Neurology® at 75: The Evolution of the Neurology Journal
Jul 9, 2026
30m 58s
Navigating the Transition From Pediatric to Adult Epilepsy Care
Jul 6, 2026
22m 02s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/20/26 | military sexual traumamigraine+3 | Dr. John Ney | American Academy of NeurologyNeurology ® Clinical Practice+1 | — | military sexual traumamigraine+3 | — | 22m 06s | ||
| 7/16/26 | ALSgenetic testing+3 | Dr. Jennifer Morganroth | Neurology ® GeneticsNeurology.org | — | ALSgenetic testing+4 | — | 14m 49s | ||
| 7/13/26 | drug marketingclinical trials+3 | Sukhun Kang | American Academy of NeurologyNeurology.org+1 | — | drug marketingclinical trials+3 | — | 17m 29s | ||
| 7/9/26 | neurologymedical journal history+3 | Dr. José Merino | NeurologyAmerican Academy of Neurology | — | Neurologymedical journal+5 | — | 30m 58s | ||
| 7/6/26 | epilepsy carepediatric care+3 | Dr. Scott Perry | American Academy of NeurologyNeurology ® Clinical Practice+1 | — | epilepsypediatric care+3 | — | 22m 02s | ||
| 7/2/26 | Parkinson diseasediagnosis+3 | Dr. Elisabeth Kurpershoek | American Academy of NeurologyNeurology.org+1 | — | Parkinson diseasediagnosis+3 | — | 16m 19s | ||
| 7/1/26 | epilepsyantiseizure medications+3 | Dr. Rosemary Dray-SpiraDr. Page Pennell+2 | American Academy of Neurology | — | epilepsyantiseizure medications+3 | — | 1h 08m 29s | ||
| 6/29/26 | hereditary ATTR amyloidosisnerve biopsy+4 | Dr. Marcus Pinto | American Academy of NeurologyNeurology.org+1 | — | ATTRv-PNnerve biopsy+5 | — | 28m 36s | ||
| 6/25/26 | strokeneurology+3 | Dr. Seemant Chaturvedi | European Stroke OrganizationNeurology.org+2 | — | stroke researchTAPIS trial+3 | — | 25m 22s | ||
| 6/22/26 | satralizumabMOGAD+3 | Dr. Michael Levy | satralizumabAmerican Academy of Neurology+1 | — | satralizumabMOGAD+5 | — | 12m 30s | ||
| 6/11/26 | diagnostic performanceembolic stroke+5 | Dr. Reza Bavarsad Shahripour | American Academy of NeurologyNeurology ® Clinical Practice | — | TCDTTE+5 | — | 20m 16s | ||
| 6/8/26 | CAR T-Cell TherapyStiff Person Syndrome+3 | Dr. Amanda L. Piquet | American Academy of NeurologyNeurology.org | — | miv-celCD19 CAR T-Cell Therapy+5 | — | 14m 17s | ||
| 6/4/26 | stroke alertsguidelines+3 | Dr. Dan Ackerman | American Academy of Neurology | — | strokeguidelines+3 | — | 18m 46s | ||
| 6/1/26 | stroke alertsacute ischemic stroke+3 | Dr. Dan Ackerman | American Academy of Neurology | — | strokethrombolytic therapy+3 | — | 21m 02s | ||
| 6/1/26 | Parkinson diseasedementia+3 | Dr. Valtteri KaasinenDr. YuHong Fu+2 | American Academy of Neurology | — | Parkinson diseasedementia with Lewy bodies+3 | — | 1h 04m 58s | ||
| 5/28/26 | prion diseaseclinical trial+3 | Dr. Sonia VallabhDr. Eric Minikel | Prion AllianceNeurology.org | — | prion diseaseclinical trial+5 | — | 26m 53s | ||
| 5/25/26 | headache medicinemigraine+4 | Dr. Tesha MonteithDr. Peter Goadsby | American Academy of NeurologyNeurology.org | — | headachemigraine+5 | — | 17m 27s | ||
| 5/21/26 | headache medicineAAN Annual Meeting+3 | Dr. Peter Goadsby | American Academy of Neurology | — | headachemedicine+5 | — | 20m 19s | ||
| 5/18/26 | inflammationbrain microstructure+3 | Dr. Breton Asken | American Academy of NeurologyNeurology.org+1 | — | inflammationcognitive decline+3 | — | 27m 24s | ||
| 5/14/26 | radiation necrosisradiation therapy+3 | Dr. Kait Nevel | Boswellia serrataAmerican Academy of Neurology | — | radiation necrosisradiation therapy+3 | — | 19m 08s |
Showing 20 of 20
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Neurology® Podcast
Peaked at #3 in Mexico, top 10 in 1 of 41 tracked markets, currently #3 in Mexico.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Mexico | — | #3 | #3 | — |
| HU | — | #18 | #18 | — |
| IS | — | #34 | #34 | — |
| HK | — | #35 | #35 | — |
| TH | — | #36 | #36 | — |
| France | — | #39 | #39 | — |
| Brazil | — | #44 | #44 | — |
| Japan | — | #46 | #46 | — |
| Mexico | — | #55 | #55 | — |
| TW | — | #58 | #58 | — |
| VN | — | #59 | #59 | — |
| CH | — | #63 | #63 | — |
| Ireland | — | #66 | #66 | — |
| SG | — | #66 | #66 | — |
| PT | — | #68 | #68 | — |
| Spain | — | #69 | #69 | — |
| Netherlands | — | #71 | #71 | — |
| PH | — | #71 | #71 | — |
| BE | — | #73 | #73 | — |
| CO | — | #74 | #74 | — |
Chart Positions
41 placements across 39 markets.
Chart Positions
41 placements across 39 markets.